The San Raffaele ALS Centre

Ospedale San Raffaele

The San Raffaele ALS Centre is dedicated to providing the highest level of care for people and families with ALS.

Ospedale San Raffaele
Ospedale San Raffaele

Our multidisciplinary team of experts is committed to providing the highest level of diagnostic accuracy and patient care. This is done using the latest neurophysiological tests, MRI scans, nerve and muscle techniques. Our scientific interests range from basic research, such as novel drug development or studies using disease models of ALS, to clinical studies (e.g clinical trials, MRI studies). We are part of the Institute of Experimental Neurology (INSPE), which is dedicated to translational research in the neuroscience field, and we collaborate with several laboratories in Italy and Europe.

Contact
Location
Ospedale San Raffaele, Via Olgettina Milano, Milan, Metropolitan City of Milan, Italy

Our Specialists

Nilo Riva

Physician scientist

Nilo Riva, Md, PhD, is a Physician scientist in Ospedale San Raffeale.

Nilo Riva
Current trials
Recruiting
Phase iii

PHOENIX trial

Industry trial
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035' for the treatment of ALS.
Read more
Recruiting
Phase iii

ADORE Trial

Industry trial
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).
Read more
Recruiting
Phase iii

COURAGE-ALS Trial

Industry trial
In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS. This clinical trial is sponsored by Cytokinetics.
Read more
Active
Phase ii

APL2-ALS-206 Trial

Industry trial
In this phase 2 study, we are investigating the safety and efficacy of the drug pegcetacoplan for the treatment of ALS. This trial is sponsored by Apellis Pharmaceuticals.
Read more
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial
In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more